mytide Therapeutics Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • mytide Therapeutics's estimated annual revenue is currently $852.5k per year.(i)
  • mytide Therapeutics's estimated revenue per employee is $77,500

Employee Data

  • mytide Therapeutics has 11 Employees.(i)
  • mytide Therapeutics grew their employee count by -48% last year.

mytide Therapeutics's People

NameTitleEmail/Phone
1
Founder and CTOReveal Email/Phone
2
CEOReveal Email/Phone
3
Director, Manufacturing and OperationsReveal Email/Phone
4
Senior Software EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M1-50%N/AN/A
#3
$5.1M3322%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M2-60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
N/A1110%N/AN/A
#10
$5.4M290%N/AN/A
Add Company

What Is mytide Therapeutics?

mytide is a groundbreaking technology startup focused on accelerating peptide therapeutics R&D. We are a multi-disciplinary team of engineers, biochemists, and computer scientists who have created the first company to take a technologically advanced approach to solving long-standing challenges in both peptide synthesis and purification. mytide's fully automated peptide manufacturing technology, coupled with predictive analytics and machine learning, is challenging decades-old paradigms to enable cost-efficient research and development, therapeutic manufacturing and therapeutic discovery. Our aim is to accelerate the discovery and development of life-saving peptide therapeutics for serious conditions ranging from metabolic conditions to cancer to inflammatory disorders to infectious diseases.

keywords:N/A

N/A

Total Funding

11

Number of Employees

$852.5k

Revenue (est)

-48%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.4M11-21%N/A
#2
$2M11-21%N/A
#3
$0.5M11-15%$11.7M
#4
$1M11N/AN/A
#5
$1M11N/AN/A